BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27643582)

  • 1. Comparison of the Radiosensitizing Effect of ATR, ATM and DNA-PK Kinase Inhibitors on Cervical Carcinoma Cells.
    Vávrová J; Zárybnická L; Jošt P; Tichý A; Řezáčová M; Šinkorová Z; Pejchal J
    Folia Biol (Praha); 2016; 62(4):167-74. PubMed ID: 27643582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ATR kinase with the selective inhibitor VE-821 results in radiosensitization of cells of promyelocytic leukaemia (HL-60).
    Vávrová J; Zárybnická L; Lukášová E; Řezáčová M; Novotná E; Sinkorová Z; Tichý A; Pejchal J; Durišová K
    Radiat Environ Biophys; 2013 Nov; 52(4):471-9. PubMed ID: 23934411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition.
    Ćmielová J; Havelek R; Vávrová J; Řezáčová M
    Med Oncol; 2015 May; 32(5):138. PubMed ID: 25801233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy.
    Massey AJ
    Cancer Lett; 2016 Dec; 383(1):41-52. PubMed ID: 27693461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin.
    Ciszewski WM; Tavecchio M; Dastych J; Curtin NJ
    Breast Cancer Res Treat; 2014 Jan; 143(1):47-55. PubMed ID: 24292814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.
    Sarkaria JN; Tibbetts RS; Busby EC; Kennedy AP; Hill DE; Abraham RT
    Cancer Res; 1998 Oct; 58(19):4375-82. PubMed ID: 9766667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization of human leukemic HL-60 cells by ATR kinase inhibitor (VE-821): phosphoproteomic analysis.
    Šalovská B; Fabrik I; Ďurišová K; Link M; Vávrová J; Řezáčová M; Tichý A
    Int J Mol Sci; 2014 Jul; 15(7):12007-26. PubMed ID: 25003641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.
    Klein C; Dokic I; Mairani A; Mein S; Brons S; Häring P; Haberer T; Jäkel O; Zimmermann A; Zenke F; Blaukat A; Debus J; Abdollahi A
    Radiat Oncol; 2017 Dec; 12(1):208. PubMed ID: 29287602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latex of Euphorbia antiquorum-induced S-phase arrest via active ATM kinase and MAPK pathways in human cervical cancer HeLa cells.
    Hsieh WT; Lin HY; Chen JH; Lin WC; Kuo YH; Wood WG; Lu HF; Chung JG
    Environ Toxicol; 2015 Sep; 30(10):1205-15. PubMed ID: 24706497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells.
    Šalovská B; Janečková H; Fabrik I; Karlíková R; Čecháková L; Ondrej M; Link M; Friedecký D; Tichý A
    PLoS One; 2018; 13(7):e0199349. PubMed ID: 30001349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.
    Scheper J; Hildebrand LS; Faulhaber EM; Deloch L; Gaipl US; Symank J; Fietkau R; Distel LV; Hecht M; Jost T
    Strahlenther Onkol; 2023 Dec; 199(12):1128-1139. PubMed ID: 36229655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.
    Sarkaria JN; Busby EC; Tibbetts RS; Roos P; Taya Y; Karnitz LM; Abraham RT
    Cancer Res; 1999 Sep; 59(17):4375-82. PubMed ID: 10485486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VE-821, an ATR inhibitor, causes radiosensitization in human tumor cells irradiated with high LET radiation.
    Fujisawa H; Nakajima NI; Sunada S; Lee Y; Hirakawa H; Yajima H; Fujimori A; Uesaka M; Okayasu R
    Radiat Oncol; 2015 Aug; 10():175. PubMed ID: 26286029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potentials of DNA-PKcs, Ku80, and ATM in enhancing radiosensitivity of cervical carcinoma cells].
    Zhuang L; Yu SY; Huang XY; Cao Y; Xiong HH
    Ai Zheng; 2007 Jul; 26(7):724-9. PubMed ID: 17626748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
    Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
    Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
    Ando K; Nakamura Y; Nagase H; Nakagawara A; Koshinaga T; Wada S; Makishima M
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.
    Hickson I; Zhao Y; Richardson CJ; Green SJ; Martin NM; Orr AI; Reaper PM; Jackson SP; Curtin NJ; Smith GC
    Cancer Res; 2004 Dec; 64(24):9152-9. PubMed ID: 15604286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzo[a]pyrene induces complex H2AX phosphorylation patterns by multiple kinases including ATM, ATR, and DNA-PK.
    Yan C; Lu J; Zhang G; Gan T; Zeng Q; Shao Z; Duerksen-Hughes PJ; Yang J
    Toxicol In Vitro; 2011 Feb; 25(1):91-9. PubMed ID: 20888899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA protein kinase-dependent G2 checkpoint revealed following knockdown of ataxia-telangiectasia mutated in human mammary epithelial cells.
    Arlander SJ; Greene BT; Innes CL; Paules RS
    Cancer Res; 2008 Jan; 68(1):89-97. PubMed ID: 18172300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of ATM, ATR, DNA-PK inhibitors on the cytotoxic and genotoxic effects of dibenzo[def,p]chrysene on human hepatocellular cancer cell line HepG2.
    Spryszyńska S; Smok-Pieniążek A; Ferlińska M; Roszak J; Nocuń M; Stępnik M
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Sep; 791():12-24. PubMed ID: 26338538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.